Eosinophilic and Neutrophilic Dermatoses

   
 
Table 3-24 Eosinophilic and Neutrophilic Dermatoses
 EntityClinical FindingsHistology/Treatment
Eosinophilic Dermatoses
 
Eosinophilic pustular folliculitis
(Ofuji’s disease)
(Figure 3.44C)
Erythematous follicular papules, pustules, and plaques with annular or serpiginous pattern, occurring in recurrent crops; typically on face in men, associated pruritus
Histology: ↑↑ eosinophils around follicles, exocytosis of eosinophils and lymphocytes into follicular epithelium
 
Treatment: indomethacin (first line), dapsone, phototherapy, oral corticosteroid or minocycline (topical steroid if mild)
 
Eosinophilic folliculitis
(AIDS-associated)
(Figure 3.44B)
Follicular papules erupting over face, ± scalp and upper trunk; associated with significant pruritus and ↓↓ CD4 count
Histology: similar to Ofuji’s disease
 
Treatment: antiretroviral therapy to ↑ CD4 count, phototherapy, topical corticosteroid with oral antihistamine
 
Angiolymphoid hyperplasia with eosinophilia
(Figure 3.44A)
Red to pink to brown papules or nodules typically over scalp, around ears or forehead, ± grouped, ± painful
Histology: vascular proliferation with ‘hobnail’ endothelial cells (protrude into lumen), surrounding eosinophils
 
Treatment: surgical excision (1/3 recur)
Neutrophilic Dermatoses
 
Behçet’s disease
(Figure 3.44D–F)
Ulcerations; acneiform, papulopustular, EN-like or pseudofolliculitis-type lesions; ± arthritis, neurologic involvement, bowel aphthae, thrombophlebitis; HLA-B51
Histology: ulcerated epidermis or superficial pustule, diffuse neutrophilic infiltrate in dermis, ± lymphocytes, histiocytes, sometimes vasculitis
 
Treatment: colchicine, dapsone, thalidomide, TNF-inhibitors

{Diagnostic criteria: oral ulcers (at least three times in 12 month period) PLUS at least two of the following:
- recurrent genital ulcers - positive pathergy test - ocular (uveitis, retinal vasculitis) - skin findings (see above)}
 
Sweet’s syndrome
(Figure 3.45A)
Tender, erythematous edematous papules and plaques typically over face or upper extremities; ± fever, malaise, leukocytosis; vesicobullous variant frequently associated with myelogenous leukemia
Histology: variable epidermal changes, superficial dermal edema with diffuse neutrophilic infiltrate ± lymphocytes, histiocytes, eosinophils, no true vasculitis
 
Treatment: oral corticosteroid × 4–6 weeks, KI, dapsone, colchicine; 30% recurrence

{Diagnostic criteria: abrupt-onset of typical eruption + typical histopathological findings PLUS 2 of following:
  1. preceded by associated infection/vaccination, drug exposure, current malignancy/inflammatory disorder or pregnancy
  2. fever and constitutional symptoms 3. leukocytosis 4. excellent response to systemic corticosteroids}
 
Pyoderma gangrenosum
(Figure 3.45B, C)

{Vesicobullous type most common with acute or chronic myelogenous leukemia}
Tender papulopustule with violaceous induration → bulla or expanding ulcer w/ purulent base, undermined border; cribriform scar; pustular, bullous, granulomatous variants

{50% PG with systemic disease: IBD, arthritis or hematological disorders (if monoclonal gammopathy, usually IgA)}
Histology: early lesions with leukocytoclasia, neutrophilic infiltrate, advanced lesions with marked necrosis of tissue with infiltrate of mononuclear cells
 
Treatment: none with consistent efficacy; oral corticosteroid ± steroid-sparing agents
      
 
   
Figure 3.44 A: Angiolymphoid hyperplasia with eosinophilia (Reprint from Baykal C, Yazganoglu K. Dermatological Diseases of the Nose and Ears. Berlin: Springer; 2010) B: Eosinophilic folliculitis (AIDS-related) (Reprint from Mildvan D (Ed). International Atlas of AIDS. New York, NY: Springer; 2008) C: Eosinophilic pustular folliculitis (Courtesy of Dr. Sophie M. Worobec) D: Behcet’s disease (Courtesy of Dr. Paul Getz) E: Behcet’s disease (Courtesy of Dr. Paul Getz) F: Behcet’s disease (Courtesy of Dr. Paul Getz)
Figure 3.44
A: Angiolymphoid hyperplasia with eosinophilia
(Reprint from Baykal C, Yazganoglu K. Dermatological Diseases of the Nose and Ears. Berlin: Springer; 2010)
B: Eosinophilic folliculitis (AIDS-related)
(Reprint from Mildvan D (Ed). International Atlas of AIDS. New York, NY: Springer; 2008)
C: Eosinophilic pustular folliculitis
(Courtesy of Dr. Sophie M. Worobec)
D: Behcet’s disease
(Courtesy of Dr. Paul Getz)
E: Behcet’s disease
(Courtesy of Dr. Paul Getz)
F: Behcet’s disease
(Courtesy of Dr. Paul Getz)
 
Figure 3.45 A: Sweet’s syndrome (Courtesy of Dr. Iris K. Aronson) B: Pyoderma gangrenosum (Courtesy of Dr. Paul Getz) C: Pyoderma gangrenosum (Courtesy of Dr. Sophie M. Worobec) D: Livedo reticularis E: Cholesterol embolus (Courtesy of Dr. Paul Getz) F: Degos disease (Reprint from Burgdorf WH, Plewig G, Landthaler M, Wolff HH, eds. Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009)
Figure 3.45
A: Sweet’s syndrome
(Courtesy of Dr. Iris K. Aronson)
B: Pyoderma gangrenosum
(Courtesy of Dr. Paul Getz)
C: Pyoderma gangrenosum
(Courtesy of Dr. Sophie M. Worobec)
D: Livedo reticularis E: Cholesterol embolus
(Courtesy of Dr. Paul Getz)
F: Degos disease
(Reprint from Burgdorf WH, Plewig G, Landthaler M, Wolff HH, eds. Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009)